New mRNA vaccine tested against deadly brain tumors
Disease control
Completed
This early-stage study tested a new mRNA vaccine called CVGBM in patients with an aggressive type of brain cancer called glioblastoma. The 37 participants had already undergone surgery and radiation treatment. Researchers gave patients seven vaccine injections over several weeks …
Phase: PHASE1 • Sponsor: CureVac • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC